The Effects of Exendin-4 Treatment on Graft Failure: An Animal Study Using a Novel Re-Vascularized Minimal Human Islet Transplant Model

• Afaf Sahraoui ,

  * E-mail: Afaf.Sahraoui2@rr-research.no

  Affiliation Institute for Surgical Research and Section for Transplantation Surgery, Oslo University Hospital, Oslo, Norway

  ⨯
• Maria Sörhede Winzell,

  Affiliation AstraZeneca R&D, Mölndal, Sweden

  ⨯
• Tracy Gorman,

  Affiliation AstraZeneca, Alderley Park, Cheshire, United Kingdom

  ⨯
• Dave M. Smith,

  Affiliation AstraZeneca R&D, Mölndal, Sweden

  ⨯
• Stanko Skrtic,

  Affiliation AstraZeneca R&D, Mölndal, Sweden

  ⨯
• Merete Hoeyem,

  Affiliation Institute for Surgical Research and Section for Transplantation Surgery, Oslo University Hospital, Oslo, Norway

  ⨯
• Shadab Abadpour,

  Affiliation Institute for Surgical Research and Section for Transplantation Surgery, Oslo University Hospital, Oslo, Norway

  ⨯
• Lars Johansson,

  Affiliation Department of Radiology, Oncology and Radiation Sciences, Uppsala University Hospital, Uppsala, Sweden

  ⨯
• Olle Korsgren,

  Affiliation Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden

  ⨯
• Aksel Foss,

  Affiliations Institute for Surgical Research and Section for Transplantation Surgery, Oslo University Hospital, Oslo, Norway, Institute of Clinical Medicine, University of Oslo, Oslo, Norway

  ⨯
• Hanne Scholz

  Affiliation Institute for Surgical Research and Section for Transplantation Surgery, Oslo University Hospital, Oslo, Norway

  ⨯